Sisu Global Completes Hemafuse Clinical Pilot in Ethiopia 

October 10, 2017  

BALTIMORE, Maryland, 10 October, 2019 –Sisu Global completed a clinical study of Hemafuse in Ethiopia to test blood quality of blood salvaged from patients with ruptured ectopic pregnancy. The results of this study confirm that Hemafuse is a safe device for the collection of salvaged blood during surgery. For those of you with a blood background, in each case, hemolysis levels were determined to be insignificant, at less than 1%. This means that our study was a resounding success!

About Sisu Global: Sisu Global is a corporation headquartered in Baltimore, Maryland. We envision a world where medical technology enables access to healthcare in every community. Right now, 80% of the world’s medical devices are designed for 10% of the world’s population. Sisu aims to change this statistic by designing and scaling medical devices made specifically for the global market. Sisu is the manufacturer of goods including the HEMAFUSE™ System. The HEMAFUSE™ is a device that can support the donor blood ecosystem by providing an option for clinicians to salvage and recycle a patient’s own blood in cases of internal bleeding. This immediate access to blood can shorten the wait time to perform surgery, increase hospital efficiency and provide access to blood where there may be no other option.

Sisu Global’s work has received numerous features such as CBS 60 Minutes, USA Today, Smithsonian.com and awards from GE Healthcare, USAID, the Gates Foundation, and many others. Sisu has presented at scientific and international conferences across the globe.  For more information, please visit our website, https://sisuglobal.health

About HEMAFUSE™: The HEMAFUSE™ is a handheld, mechanical medical device for intraoperative autotransfusion of blood collected from an internal hemorrhage, meant to replace or augment donor blood in emergency situations.  The HEMAFUSE™ is a device that can support the donor blood ecosystem by providing an option for clinicians to salvage and recycle a patient’s own blood in cases of internal bleeding. This immediate access to blood can shorten the wait time to perform surgery, increase hospital efficiency and provide access to blood where there may be no other option.